Pinteon Therapeutics

Company focused on the discovery and development of therapies targeting therapeutics for cancer, CNS and autoimmune diseases

placeConcord, Massachusetts, United States calendar_todayFounded 2014 groups8 employees language pinteon.com

Registered entities

Innovation

2 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 416 times.

YearFilings
20161
20181
20191
20202
20211
20231
20241

Investor mix

2 investors on record; lead investors include Morningside.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon